Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12121540 | CBL inhibitors and compositions for use in adoptive cell therapy | Jennifa Gosling, Arthur Sands, Sarah Whelan | 2024-10-22 |
| 12016860 | Combination therapies with Cbl-b inhibitor compounds | Marilena GALLOTTA | 2024-06-25 |
| 11918648 | Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer | Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein +3 more | 2024-03-05 |
| 10751412 | Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer | Ying Yu, Andrew Evan Denker, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein +3 more | 2020-08-25 |
| 10369168 | Administration of polynucleotide toll-like receptor 9 agonists for treating cancer | Robert L. Coffman | 2019-08-06 |
| 10111899 | Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung | Robert L. Coffman | 2018-10-30 |
| 9993495 | Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung | Robert L. Coffman | 2018-06-12 |
| 9868955 | Human toll-like receptor inhibitors and methods of use thereof | Karen L. Fearon, Franck Barrat | 2018-01-16 |
| 9476053 | Methods and compositions for inhibition of immune responses and autoimmunity | Franck Barrat, Robert L. Coffman, Tracy Matray | 2016-10-25 |
| 9347064 | Methods of treatment using TLR7 and/or TLR9 inhibitors | Franck Barrat, Robert L. Coffman | 2016-05-24 |
| 9228184 | Human toll-like receptor inhibitors and methods of use thereof | Karen L. Fearon, Franck Barrat | 2016-01-05 |
| 9063123 | Transgenic mice expressing human toll-like receptor 8 | Franck Barrat, Robert L. Coffman | 2015-06-23 |
| 8962579 | Methods and compositions for inhibition of immune responses and autoimmunity | Franck Barrat, Robert L. Coffman, Tracy Matray | 2015-02-24 |
| 8940310 | Methods of treatment using TLR7 and/or TLR9 inhibitors | Franck Barrat, Robert L. Coffman | 2015-01-27 |